CClinicalTrials.gg
RecruitingNCT07130305Updated Aug 19, 2025

is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever

An interventional study of whole body vibration plus usual care and usual care in Familial Mediterranean Fever, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-08-19.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled May 2025, registered Aug 2025).
  • Started May 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
Female
01

Study summary

Familial mediterranean fever (FMF) is common in mediterranean region. this disorder is connected with deterioration in functional performance, fitness of cardiorespiration, muscle strength, and bone mass

Read the detailed description

Familial mediterranean fever (FMF adolescent girls ) will be collected to be cateogarized to vibration group (vibration group) or control grouping. every group OF FMF will contain 20 FMF adolescent girls. both groups will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will receive three sessions of 20-min whole body vibration in the week for 6 months

02

Conditions studied

  • Familial Mediterranean Fever
03

In context

Familial Mediterranean Fever

69 studies on the registry are indexed under Familial Mediterranean Fever; 27 are open to participants now.

This study's planned enrollment of 40 is close to the median of 40 across 32 interventional studies indexed under Familial Mediterranean Fever.

Browse Familial Mediterranean Fever studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

FMF adolecent girls ages 13 -17 years forty patients

Exclusion criteria

Exclusion Criteria:

cardiac problems renal problems liver problems diabetes brain problems

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    vibration group

    vibration group OF FMF will contain 20 FMF adolescent girls. who will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will receive also three sessions of 20-min whole body vibration in the week for 6 months

    Other: whole body vibration plus usual care

  • Active comparator
    control group

    control group of Familial mediterranean fever (20 FMF adolescent girls ) will receive vitamin D and their traditional colchicine doses daily for six months.

    Other: usual care

Interventions

  • Otherwhole body vibration plus usual care

    Familial mediterranean fever (20 FMF adolescent girls ) will be in this vibration group who will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will also receive three sessions of 20-min whole body vibration in the week for 6 months

  • Otherusual care

    Familial mediterranean fever (20 FMF adolescent girls ) will be in this control group who will receive vitamin D and their traditional colchicine doses daily for six months.

06

What researchers measure

Primary outcomes

  1. bone mineral density

    it is a measure for bone density at 2-4 lumbar vertebrae

    Time frame: it will be measured after 6 months

Secondary outcomes

  1. z score

    it is a score for measure for bone mass at 2-4 lumbar vertebrae

    Time frame: it will be measured after 6 months

  2. vitamin D

    it will measured in plasma as serum 25-hydroxyvitamin D

    Time frame: it will be measured after 6 months

  3. osteoprotegerin

    it will measured in plasma

    Time frame: it will be measured after 6 months

  4. quadriceps torque

    it will measured in dominant side

    Time frame: it will be measured after 6 months

  5. Standing long jump test

    it is an indicator for functional performance

    Time frame: it will be measured after 6 months

  6. Thirty second sit to stand test

    it is an indicator for functional performance

    Time frame: it will be measured after 6 months

  7. Ruffier index

    it is an indicator for cardiorespirtory fittness

    Time frame: it will be measured after 6 months

07

Study locations

1 of 1 sites recruiting
  • Cairo University
    Giza, Dokki, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07130305
Lead sponsor
Cairo University
Responsible party
Ali Mohamed Ali ismail (lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Cairo University) — Principal investigator
First posted
Aug 19, 2025
Start date
May 8, 2025
Primary completion
Jan 8, 2026 (estimated)
Completion
Jan 15, 2026 (estimated)
Last update
Aug 19, 2025

Study contacts

Ali MA Ismail, lecturer
Contact
ali.mohamed@pt.cu.edu.eg
01005154209
Ali Ismail
Contact
allooka2012@gmail.com
Ali MA Ismail, lecturer
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion